Hemopexin down‐regulates LPS‐induced proinflammatory cytokines from macrophages
暂无分享,去创建一个
J. Cavaillon | H. S. Warren | Laura Beasley-Topliffe | Tian Lin | Guangjie Sun | X. Liang | H. Warren | L. Beasley-Topliffe | Laura Beasley‐Topliffe | Xueya Liang
[1] J. Matsuda,et al. [Hemopexin]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.
[2] S. Chung,et al. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. , 2008, The Journal of clinical investigation.
[3] S. Chadban,et al. TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.
[4] F. Chandad,et al. Hemoglobin and LPS Act in Synergy to Amplify the Inflammatory Response , 2007, Journal of dental research.
[5] R. Figueiredo,et al. Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.
[6] J. Weiss,et al. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells , 2007, Immunologic research.
[7] Hae-Sook Shin,et al. MyD88-Dependent and MyD88-Independent Pathways in Synergy, Priming, and Tolerance between TLR Agonists1 , 2007, The Journal of Immunology.
[8] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[9] M. Sitkovsky,et al. Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.
[10] P. Højrup,et al. Identification of the receptor scavenging hemopexin-heme complexes. , 2005, Blood.
[11] R. Munford. Invited review: Detoxifying endotoxin: time, place and person , 2005 .
[12] S. Akira,et al. Toll-like receptors in innate immunity. , 2004, International immunology.
[13] F. Bach,et al. Heme oxygenase-1: unleashing the protective properties of heme. , 2003, Trends in immunology.
[14] Peter A. Ward,et al. Novel strategies for the treatment of sepsis , 2003, Nature Medicine.
[15] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[16] G. Cooke,et al. Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.
[17] Jesse D. Roberts,et al. Bacterial Peptidoglycan-associated Lipoprotein Is Released into the Bloodstream in Gram-negative Sepsis and Causes Inflammation and Death in Mice* , 2002, The Journal of Biological Chemistry.
[18] F. Altruda,et al. Hemopexin: structure, function, and regulation. , 2002, DNA and cell biology.
[19] J. Richardson,et al. Free hemoglobin enhances tumor necrosis factor-alpha production in isolated human monocytes. , 2002, The Journal of trauma.
[20] Tzong-Shyuan Lee,et al. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice , 2002, Nature Medicine.
[21] H. Namiki,et al. Hemopexins suppress phorbol ester-induced necrosis of polymorphonuclear leucocytes. , 2001, Cell structure and function.
[22] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[23] T. Calandra,et al. Role of Plasma, Lipopolysaccharide-Binding Protein, and CD14 in Response of Mouse Peritoneal Exudate Macrophages to Endotoxin , 2001, Infection and Immunity.
[24] K. Takeda,et al. Cutting Edge: Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages1 , 2000, The Journal of Immunology.
[25] A. Choi,et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.
[26] J. Bernier,et al. Increased burn-induced immunosuppression in lipopolysaccharide-resistant mice. , 2000, Cellular immunology.
[27] D. Su,et al. Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice. , 1999, Critical Care Medicine.
[28] P. Tobias,et al. Lipopolysaccharide (LPS)-binding Proteins BPI and LBP Form Different Types of Complexes with LPS* , 1997, The Journal of Biological Chemistry.
[29] D. Su,et al. Hemoglobin increases mortality from bacterial endotoxin , 1997, Infection and immunity.
[30] R. Bone,et al. Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.
[31] J. Gegner,et al. Lipopolysaccharide (LPS) Signal Transduction and Clearance , 1995, The Journal of Biological Chemistry.
[32] R. Hotchkiss,et al. Hyperthermia protects mice against the lethal effects of endotoxin. , 1993, The American journal of physiology.
[33] P. Elsbach,et al. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. , 1993, Immunobiology.
[34] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[35] R. Ulevitch,et al. Structure and function of lipopolysaccharide binding protein. , 1990, Science.
[36] H. S. Warren,et al. Neutralization of bacterial lipopolysaccharides by human plasma , 1985, Journal of clinical microbiology.
[37] H. S. Warren,et al. Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate , 1985, Journal of clinical microbiology.
[38] J. Levin,et al. THE ROLE OF ENDOTOXIN IN THE EXTRACELLULAR COAGULATION OF LIMULUS BLOOD. , 1964, Bulletin of the Johns Hopkins Hospital.
[39] R. Munford. Detoxifying endotoxin: time, place and person. , 2005, Journal of endotoxin research.
[40] W. Mileski. Free hemoglobin enhances tumor necrosis factor-α production in isolated human monocytes: Editorial comment , 2002 .
[41] C. Whitfield,et al. Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.
[42] K. Imanishi,et al. Hemopexin levels in mice. , 1984, International journal of immunopharmacology.